Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Exchange Rate Effect (2023 - 2025)

Rein Therapeutics (RNTX) has disclosed Exchange Rate Effect for 3 consecutive years, with -$18000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect fell 1700.0% to -$18000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$45000.0 through Dec 2025, up 29.69% year-over-year, with the annual reading at -$44000.0 for FY2025, N/A changed from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$18000.0 at Rein Therapeutics, up from -$26000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was -$1000.0 in Q4 2024, with the low at -$63000.0 in Q4 2023.
  • Average Exchange Rate Effect over 3 years is -$27000.0, with a median of -$22000.0 recorded in 2025.
  • The sharpest move saw Exchange Rate Effect soared 98.41% in 2024, then crashed 1700.0% in 2025.
  • Over 3 years, Exchange Rate Effect stood at -$63000.0 in 2023, then skyrocketed by 98.41% to -$1000.0 in 2024, then plummeted by 1700.0% to -$18000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$18000.0, -$26000.0, and -$1000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.